![]() |
市場調査レポート
商品コード
1746995
インターベンショナルカーディオロジーデバイスの日本市場:製品別、エンドユーザー別、地域別、2025年~2033年Japan Interventional Cardiology Devices Market Report by Product (Stents, Interventional Catheters, PTCA Guidewires, Balloon Inflation Device, PTCA Balloons), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2025-2033 |
||||||
カスタマイズ可能
|
インターベンショナルカーディオロジーデバイスの日本市場:製品別、エンドユーザー別、地域別、2025年~2033年 |
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 121 Pages
納期: 5~7営業日
|
日本のインターベンショナルカーディオロジーデバイス市場規模は2024年に11億米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに24億米ドルに達し、2025年から2033年にかけて8.3%の成長率(CAGR)を示すと予測しています。心臓疾患の有病率の上昇、最近の医療技術の進歩、支援政策の導入、従来の手術よりも低侵襲(MI)手技への嗜好の高まりなどが、市場を牽引する主な要因となっています。
Japan interventional cardiology devices market size reached USD 1.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.4 Billion by 2033, exhibiting a growth rate (CAGR) of 8.3% during 2025-2033. The rising prevalence of cardiac ailments, recent advancements in medical technology, introduction of supportive policies, and the growing preference for minimally invasive (MI) procedures over traditional surgeries represent some of the key factors driving the market.
Interventional cardiology devices refer to a broad range of specialized tools and equipment utilized in the catheter-based treatment of structural heart diseases. They include stents, catheters, guidewires, balloons, and vascular closure devices, among others. Interventional cardiology devices possess various features, including minimally invasive (MI) nature, precision, flexibility, and advanced technological integration. They are employed in a variety of applications, including angioplasty, stent placement, valvuloplasty, congenital heart defect correction, percutaneous valve repair, and coronary thrombectomy. Interventional cardiology devices aid in improving patient outcomes, reducing recovery times, lowering the risk of infection, minimizing hospital stays, decreasing procedural discomfort, and enhancing diagnostic accuracy. In addition, they are known for their cost-effectiveness in the long term, lower surgical risks, high success rates, and ability to cater to high-risk patients who are not candidates for open-heart surgery.
The rising prevalence of cardiac ailments in the geriatric population, contributing to the heightened demand for advanced cardiac care, including interventional procedures, is propelling the market growth. Additionally, the increasing prevalence of lifestyle-related diseases, such as hypertension, obesity, and diabetes, which escalates the risk of cardiovascular diseases, is driving the market growth. Besides this, recent advancements in medical technology, leading to the development of more sophisticated and effective interventional cardiology devices, are positively influencing the market growth. Furthermore, the introduction of supportive policies and investments by the government in healthcare infrastructure is bolstering the market growth. In addition, the growing preference for MI procedures over traditional surgeries, owing to their reduced recovery times and lower risks, is catalyzing the market growth. Apart from this, the rising healthcare expenditure, coupled with enhanced insurance coverage for advanced medical procedures, is providing a considerable boost to the market growth. Moreover, the increasing number of specialized cardiologists and healthcare facilities that are equipped to perform interventional cardiology are positively affecting the market growth. Along with this, the growing collaboration and partnerships among leading global and local medical device companies for technology transfer and product development are stimulating the market growth. In addition, the rising awareness about cardiovascular diseases and their treatments among the Japanese population is driving the market growth. Furthermore, the ongoing research and clinical trials aiming to improve the efficacy and safety of interventional cardiology devices are strengthening the market growth. Besides this, the significant improvements in healthcare infrastructure, including the availability of advanced medical facilities that can support the adoption of interventional cardiology devices, are fueling the market growth. Additionally, the widespread availability of strong clinical evidence supporting the effectiveness and safety of interventional cardiology devices is favoring the market growth.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.